[3H]noscapine binding sites in brain: Relationship to indoleamines and the phosphoinositide and adenylyl cyclase messenger systems

Robert J. Mourey, Ted M Dawson, Roxanne K Barrow, Anne E. Enna, Solomon H Snyder

Research output: Contribution to journalArticle

Abstract

High affinity [3H]noscapine binding sites are brain specific, ion insensitive, and present in a variety of species and show strict structure-activity requirements. Among neurotransmitter-related structures, indoleamines and β-carbolines display highest affinity for [3H]noscapine sites. Noscapine inhibits carbachol-stimulated phosphoinositide turnover in guinea pig and rat brain slices, with structural analogs possessing similar relative potencies for binding to [3H]noscapine binding sites and inhibiting phosphoinositide turnover. Noscapine and its derivatives also markedly enhance the ability of forskolin to augment cAMP levels in brain slices, with relative potencies paralleling affinities for noscapine binding sites.

Original languageEnglish (US)
Pages (from-to)619-626
Number of pages8
JournalMolecular Pharmacology
Volume42
Issue number4
StatePublished - Oct 1992

Fingerprint

Noscapine
Phosphatidylinositols
Adenylyl Cyclases
Binding Sites
Brain
Carbolines
Carbachol
Colforsin
Neurotransmitter Agents
Guinea Pigs
Ions

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{8f575141fc9c4e759e04143c6c847f11,
title = "[3H]noscapine binding sites in brain: Relationship to indoleamines and the phosphoinositide and adenylyl cyclase messenger systems",
abstract = "High affinity [3H]noscapine binding sites are brain specific, ion insensitive, and present in a variety of species and show strict structure-activity requirements. Among neurotransmitter-related structures, indoleamines and β-carbolines display highest affinity for [3H]noscapine sites. Noscapine inhibits carbachol-stimulated phosphoinositide turnover in guinea pig and rat brain slices, with structural analogs possessing similar relative potencies for binding to [3H]noscapine binding sites and inhibiting phosphoinositide turnover. Noscapine and its derivatives also markedly enhance the ability of forskolin to augment cAMP levels in brain slices, with relative potencies paralleling affinities for noscapine binding sites.",
author = "Mourey, {Robert J.} and Dawson, {Ted M} and Barrow, {Roxanne K} and Enna, {Anne E.} and Snyder, {Solomon H}",
year = "1992",
month = "10",
language = "English (US)",
volume = "42",
pages = "619--626",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "4",

}

TY - JOUR

T1 - [3H]noscapine binding sites in brain

T2 - Relationship to indoleamines and the phosphoinositide and adenylyl cyclase messenger systems

AU - Mourey, Robert J.

AU - Dawson, Ted M

AU - Barrow, Roxanne K

AU - Enna, Anne E.

AU - Snyder, Solomon H

PY - 1992/10

Y1 - 1992/10

N2 - High affinity [3H]noscapine binding sites are brain specific, ion insensitive, and present in a variety of species and show strict structure-activity requirements. Among neurotransmitter-related structures, indoleamines and β-carbolines display highest affinity for [3H]noscapine sites. Noscapine inhibits carbachol-stimulated phosphoinositide turnover in guinea pig and rat brain slices, with structural analogs possessing similar relative potencies for binding to [3H]noscapine binding sites and inhibiting phosphoinositide turnover. Noscapine and its derivatives also markedly enhance the ability of forskolin to augment cAMP levels in brain slices, with relative potencies paralleling affinities for noscapine binding sites.

AB - High affinity [3H]noscapine binding sites are brain specific, ion insensitive, and present in a variety of species and show strict structure-activity requirements. Among neurotransmitter-related structures, indoleamines and β-carbolines display highest affinity for [3H]noscapine sites. Noscapine inhibits carbachol-stimulated phosphoinositide turnover in guinea pig and rat brain slices, with structural analogs possessing similar relative potencies for binding to [3H]noscapine binding sites and inhibiting phosphoinositide turnover. Noscapine and its derivatives also markedly enhance the ability of forskolin to augment cAMP levels in brain slices, with relative potencies paralleling affinities for noscapine binding sites.

UR - http://www.scopus.com/inward/record.url?scp=0027010259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027010259&partnerID=8YFLogxK

M3 - Article

C2 - 1331753

AN - SCOPUS:0027010259

VL - 42

SP - 619

EP - 626

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 4

ER -